rethinkPeptides Search
Menu
Study breakdown

Depot Drug Delivery for Depression: Long-Acting Peptide and Protein Formulations

evidence
The takeaway

Depot-based delivery systems for antidepressants and neuropeptides offer sustained release, improved compliance, and reduced dosing frequency — advancing long-acting peptide delivery for psychiatric applications.

Key finding

Depot-based delivery systems for antidepressants and neuropeptides offer sustained release, improved compliance, and reduced dosing frequency — advanc

What the researchers found

Depot-based delivery systems for antidepressants and neuropeptides offer sustained release, improved compliance, and reduced dosing frequency — advancing long-acting peptide delivery for psychiatric applications.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2011.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Depot Drug Delivery for Depression: Long-Acting Peptide and Protein Formulations
What was found?
Depot-based delivery systems for antidepressants and neuropeptides offer sustained release, improved compliance, and reduced dosing frequency — advancing long-acting peptide delivery for psychiatric applications.

Read the original research

Depot based drug delivery system for the management of depression.

Current drug delivery, 8(5), 483-93

Citation

Pilaniya, Urmila; Khatri, Kapil; Patil, U K. (2011). Depot based drug delivery system for the management of depression.. Current drug delivery, 8(5), 483-93.